Meet Our Industry Partners and Sponsors
Diamond Sponsors
Lilly was founded in 1876 by Colonel Eli Lilly, a man committed to creating high-quality medicines that met real needs in an era of unreliable elixirs peddled by questionable characters. His charge to the generations of employees who have followed was this: “Take what you find here and make it better and better.”
More than 140 years later, we remain committed to his vision through every aspect of our business and the people we serve starting with those who take our medicines, and extending to health care professionals, employees and the communities in which we live.
Gold Sponsors
Powering precision proteomics with unrivaled sensitivity and simplicity.
Alamar Biosciences offers automated, high throughput solutions for ultra-high sensitivity protein analysis across a range of multiplex levels in liquid biopsy samples. The NULISA™ Platform allows for a fully automated workflow with less than 30 minutes hands-on time from sample to data. Learn more at alamarbio.com.
Amgen is committed to unlocking the potential of biology for patients suffering from serious illnesses by discovering, developing, manufacturing, and delivering innovative human therapeutics. This approach begins by using tools like advanced human genetics to unravel the complexities of disease and understand the fundamentals of human biology.
For over 30 years, the Autoimmune Association has been a pioneer in serving autoimmune patients, sponsoring research, advocating for access to healthcare, and fostering collaboration to identify and explore the common threads that link autoimmune diseases.
Established through the remarkable determination of Founder Virginia T. Ladd, the Autoimmune Association has transformed into an internationally recognized leader, reaching over 60 countries worldwide. To mark its 30-year legacy and global impact on the autoimmune community, the name of the organization was changed from its original name, the American Autoimmune Related Diseases Association (AARDA).
BD is one of the largest global medical technology companies in the world and is advancing the world of healthTM by improving medical discovery, diagnostics and the delivery of care. The company supports the heroes on the frontlines of healthcare by developing innovative technology, services and solutions that help advance both clinical therapy for patients and clinical process for healthcare providers. BD and its 75,000 employees have a passion and commitment to help enhance the safety and efficiency of clinicians’ care delivery process, enable laboratory scientists to accurately detect disease and advance researchers’ capabilities to develop the next generation of diagnostics and therapeutics. BD has a presence in virtually every country and partners with organizations around the world to address some of the most challenging global health issues. By working in close collaboration with customers, BD can help enhance outcomes, lower costs, increase efficiencies, improve safety and expand access to healthcare.
About Revvity and BioLegend (part of Revvity)
At Revvity, “impossible” is inspiration, and “can’t be done” is a call to action. Revvity provides health science solutions, technologies, expertise and services that deliver complete workflows from discovery to development, and diagnosis to cure. Revvity is revolutionizing what’s possible in healthcare, with specialized focus areas in translational multi-omics technologies, biomarker identification, imaging, prediction, screening, detection and diagnosis, informatics and more. With 2023 revenue of more than $2.7 billion and over 11,000 employees, Revvity serves customers across pharmaceutical and biotech, diagnostic labs, academia and governments. It is part of the S&P 500 index and has customers in more than 190 countries.
Stay updated by following our Newsroom, LinkedIn, X, YouTube, Facebook and Instagram.
At Gilead, we’re committed to creating a healthier world for everyone – no matter the challenges ahead of us. For more than 30 years, we’ve pursued the impossible, chased it down, tackled it for answers and surrounded it for a way in. We have worked tirelessly to bring forward medicines for life-threatening diseases.
Through bold and transformative science, we’re driving innovation that has the potential to become the next generation of life-changing medicines. Our ambition is evident in our mission. Because the impossible is not impossible. It’s what’s next.
Regeneron is a leading biotechnology company that invents, develops and commercializes life-transforming medicines for people with serious diseases. Founded and led for nearly 35 years by physician-scientists, our unique ability to repeatedly and consistently translate science into medicine has led to numerous FDA-approved treatments and product candidates in development, almost all of which were homegrown in our laboratories. Our medicines and pipeline are designed to help patients with eye diseases, allergic and inflammatory diseases, cancer, cardiovascular and metabolic diseases, pain, hematologic conditions, infectious diseases and rare diseases.
Regeneron is accelerating and improving the traditional drug development process through our proprietary VelociSuite® technologies, such as VelocImmune®, which uses unique genetically-humanized mice to produce optimized fully-human antibodies and bispecific antibodies, and through ambitious research initiatives such as the Regeneron Genetics Center, which is conducting one of the largest genetics sequencing efforts in the world.
For more information, please visit www.Regeneron.com or follow @Regeneron on Twitter.
We are an innovative global healthcare company, driven by one purpose: we chase the miracles of science to improve people’s lives. Our team, across the world, is dedicated to transforming the practice of medicine by working to turn the impossible into the possible. We provide potentially life-changing treatment options and life-saving vaccine protection to millions of people globally, while putting sustainability and social responsibility at the center of our ambitions.
Silver Sponsors
Bronze Sponsors
This activity was supported by an educational grant from Grifols
Industry Opportunities
FOCIS values industry collaboration and has worked hard to provide opportunities for 360° annual participation.
Annual Sponsorship Packages
FOCIS offers a variety of sponsorship packages to help your organization connect with the translational scientist in the FOCIS community. Packages include Annual Meeting and year-round promotions, such as course, session or reception sponsorship; invitations to receptions and private meetings; digital and print marketing, promotion across social media channels, print and online Annual Meeting marketing; and complimentary individual memberships and Annual Meeting registration passes. Packages are designed by level (diamond, platinum, gold, etc.).
Contact FOCIS Executive Director Caley Mutrie at cmutrie@focisnet.org or 414-359-1670 to discuss available options.
Annual Meeting Sponsor and Exhibitor Opportunities
FOCIS offers many opportunities to get your name in front of FOCIS Annual Meeting attendees. Consider hosting an exhibit booth or sponsoring a scientific session, networking event, travel award, signage, printed program ads and more.
Contact FOCIS Executive Director Caley Mutrie at cmutrie@focisnet.org or 414-359-1670 to discuss available options.
Year-round Visibility and Marketing Opportunities
FOCIS is pleased to offer a variety of communication sponsorship opportunities and visibility items that may be purchased individually or bundled. Opportunities include ads in FOCIS e-publications, dedicated emails, and more. Contact FOCIS Executive Director Caley Mutrie at cmutrie@focisnet.org or 414-359-1670 to discuss bundling options and pricing.
FOCIS Sponsorship and Promotions Brochure
In the FOCIS Sponsorship and Promotions Brochure, find many ways to participate that will boost visibility, educate and provide return on investment.
FCE Trainee Travel Awards
Promote trainee and fellow development by sponsoring an FCE travel award. The travel award supports costs of an FCE trainee attending a FOCIS educational program.
Questions?
To learn more about partnering with the FOCIS Centers of Excellence, contact FOCIS Executive Director Caley Mutrie at cmutrie@focisnet.org or 414-359-1670.
Post a Job Opportunity
Looking to recruit for a new position? Post the position to the FOCIS Career Center.